The principle goal was to detect suitable analytical targets by examining human hepatocyte incubation samples with high-resolution mass spectrometry (HRMS) and to confirm the final results in genuine urine specimens and to find out AB-FUBINACA's metabolic security in human liver microsomes and as opposed hepatocyte and urine benefits with in silico